Finance

Lists
Why is INGN down 2,21%?
Dive Deeper
INGN:NASDAQ
Inogen Inc
5,30 USD
-2,21%
(-0,12) 1D
5,30 USD
0,00% (0,00)
After hours
Closed: 20-ноя., 16:00:02 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INGN...
Open
5,40 USD
High
5,70 USD
Low
5,24 USD
Mkt. cap
137,81 млн
Avg. vol.
277,42 миң
Volume
351,93 миң
52-wk high
7,67 USD
52-wk low
5,04 USD
EPS
-0,90 USD
Beta
1,51
Shares outstanding
26,00 млн
No. of employees
753
Open
5,40 USD
High
5,70 USD
Low
5,24 USD
Mkt. cap
137,81 млн
Avg. vol.
277,42 миң
Volume
351,93 миң
52-wk high
7,67 USD
52-wk low
5,04 USD
EPS
-0,90 USD
Beta
1,51
Shares outstanding
26,00 млн
No. of employees
753
News stories
From web sources and news partners
About Inogen Inc
CEOKevin R. Smith
Employees753
Founded2001
HeadquartersГолета, Калифорния, Америка Кошмо Штаттары
SectorHealth Care
IndustryMedical device
Analyst ratings
Based on 2 analysts giving stock ratings to INGN in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for INGN in the last 3 months.
Highest
Current 5,30 USD
12,00 USD (+126,42%)
Average
10,75 USD (+102,83%)
Lowest
9,50 USD (+79,25%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ilya Zubkov
Freedom Capital Markets
Buy
Maintained
9,50 USD
+79,2%
11/10/2026
Michael Matson
Needham
Buy
Maintained
12,00 USD
+126,4%
10/01/2026
Unknown Analyst
B. Riley Securities
Buy
Initiated
14,00 USD
+164,2%
08/07/2026
Anderson Schock
B. Riley Securities
Buy
Reiterated
14,00 USD
+164,2%
01/21/2026
Last report
2026-ж., 6-ноя.
Fiscal period
Q3 2026
-0,02 USD / -0,06 USD
+66,67%beat
Revenue / Est. (USD)
77,19 млн / 92,25 млн
-16,32%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
2026-ж. сен.
Revenue
81,72 млн
85,11 млн
95,08 млн
77,19 млн
Cost of goods sold
46,48 млн
47,25 млн
-
43,18 млн
Cost of revenue
46,48 млн
47,25 млн
-
43,18 млн
Research and development expenses
5,32 млн
5,10 млн
-
5,40 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
39,23 млн
41,18 млн
-
32,80 млн
Operating expense
44,54 млн
46,28 млн
-
38,21 млн
Total operating expenses
91,03 млн
93,53 млн
-
81,39 млн
Operating income
-9,31 млн
-8,42 млн
-
-4,20 млн
Other non operating income
-520,00 миң
-42,00 миң
-
73,00 миң
EBT including unusual items
-7,36 млн
-8,50 млн
-
-14,64 млн
EBT excluding unusual items
-7,36 млн
-7,58 млн
-
-3,26 млн
Income tax expense
-236,00 миң
-174,00 миң
-
153,00 миң
Effective tax rate
3,21%
2,05%
-
-1,04%
Other operating expenses
-
-
-
-
Net income
-7,13 млн
-8,32 млн
-
-16,16 млн
Net profit margin
-8,72%
-9,78%
-
-20,93%
Earnings per share
-0,15
-0,14
-
-0,02
Interest and investment income
1,16 млн
880,00 миң
-
870,00 миң
Interest expense
-
-
-
-
Net interest expenses
1,16 млн
880,00 миң
-
870,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-4,27 млн
-3,52 млн
-
-2,00 млн
Gain or loss from assets sale
572,00 миң
563,00 миң
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору